![Cong Xu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cong Xu
Vorsitzender bei
IMPACT THERAPEUTICS, INC
Profil
Cong Xu is currently Chairman at IMPACT Therapeutics, Inc. since 2020.
Dr. Xu is a Non-Executive Director at EdiGene Inc. since 2018 and at ImmuneOnco Biopharmaceuticals (Shanghai), Inc. since 2020.
Dr. Xu is a Director at Shanghai Kechow Pharma, Inc. and Shanghai Allist Pharmaceuticals Co., Ltd., both since 2024.
Formerly, Dr. Xu was a Director at Arrivent BioPharma, Inc. from 2022 to 2023.
Dr. Xu earned a doctorate from Clemson University in 2012, a doctorate from the University of British Columbia in 2018, and an undergraduate degree from Tongji Medical College of Huazhong University of Science & Technology in 2007.
Aktive Positionen von Cong Xu
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC. | Direktor/Vorstandsmitglied | 01.10.2020 |
| IMPACT THERAPEUTICS, INC | Vorsitzender | 01.07.2020 |
| SHANGHAI ALLIST PHARMACEUTICALS CO., LTD. | Direktor/Vorstandsmitglied | 26.11.2024 |
Shanghai Kechow Pharma, Inc.
 Shanghai Kechow Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Direktor/Vorstandsmitglied | 12.07.2024 |
EdiGene Inc.
 EdiGene Inc. Pharmaceuticals: MajorHealth Technology Develops disruptive cells and gene therapies for patients with oncology, neuromuscular and autoimmune diseases | Direktor/Vorstandsmitglied | 01.01.2018 |
Ehemalige bekannte Positionen von Cong Xu
| Unternehmen | Position | Ende |
|---|---|---|
| ARRIVENT BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 01.12.2023 |
Ausbildung von Cong Xu
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
65
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Clemson University
 Clemson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Allist Pharmaceuticals Co., Ltd.
 Shanghai Allist Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops chemical, pharmaceutical, and bio technology products | Health Technology |
Tongji Medical College of Huazhong University of Sci & Tech
 Tongji Medical College of Huazhong University of Sci & Tech Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IMPACT Therapeutics, Inc.
 IMPACT Therapeutics, Inc. BiotechnologyHealth Technology Operates as a commercial-stage biotechnology company that develops anti-cancer therapies and pharmaceutical products | Health Technology |
EdiGene Inc.
EdiGene Inc. Pharmaceuticals: MajorHealth Technology Develops disruptive cells and gene therapies for patients with oncology, neuromuscular and autoimmune diseases | Health Technology |
Shanghai Kechow Pharma, Inc.
Shanghai Kechow Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd.
 ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a early-stage biopharmaceutical company which develops and commercializes novel cancer immunotherapeutic products | Health Technology |
Arrivent BioPharma, Inc.
 Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
